Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

President Donald Trump signed an executive order Thursday aimed at blocking states from crafting their own regulations for ...

Patients want to know, “When should I get an mpox vaccine booster?” But the research to answer their question isn’t available ...

The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...

Democratic and Republican proposals on health insurance voted down as year-end expiration of subsidies draws closer.

European policymakers unveiled an agreement for the biggest shakeup to E.U. pharmaceutical policy in two decades.

SAMHSA, amid continuing crises in mental health and addiction, has been hit by heavy cuts in personnel and funding under ...

A single-dose oral antibiotic from a new class of drugs was as effective as the previous standard of care at treating ...

Is a new obesity drug making people lose too much weight? Plus catch up on #ASH25 and hear how the country's scientific ...

Tune into the latest episode of STATus Report for host Alex Hogan's recap of the influential #ASH25 medical conference.

Eli Lilly’s next-generation obesity drug led to what appears to be the most weight loss seen so far in a late-stage trial, ...

Leading efforts to translate research into treatments at the NIH had felt, for physician Josh Fessel, like the way he could ...